Bought
Maintained
Sold
Other funds holding ADNT
DSA
BHG
LAM
NM
LBA
LCM
Aviva's ADNT Position: Q1 2019 in Review
Aviva sold out of Adient (ADNT) in Q1 2019, closing a stake of 34,971 shares — an estimated $527K sold.
Aviva first reported a position in ADNT in Q4 2016 and held it in 9 quarters. The position peaked at $4.99M in Q3 2017. 353 funds tracked by Wall St. Rank hold ADNT as of Q1 2019.
- Aviva reported no remaining Adient position as of Q1 2019 after selling out during the quarter.
- Aviva sold 34,971 Adient shares in Q1 2019, an estimated $527K.
- Aviva first reported a position in Adient in Q4 2016 and held it in 9 quarters.
- Aviva's Adient position peaked at $4.99M in Q3 2017.
- 353 funds tracked by Wall St. Rank held Adient as of Q1 2019.
Based on Aviva's 13F filing for Q1 2019, filed 14 May 2019.